A1 Pharmaceuticals Plc

Latest News >>

A1 Pharmaceuticals the next generation Neil Pauffley wins British Aegon Masters Tour 10/12/2016 Neil Pauffley wins Aegon F6 Futures Barnstaple 13/11/2016 Chairman of Bromley British Legion lead a beautiful ceremony to remember the fallen on 11/11 at 11am at Bromley cenotaph – “lest we forget they gave their tomorrow for our today “ Thames Gateway Business Awards: Managing Director Gary Lewis raised money for local hospice with winning bid for a signed West Ham United shirt Neil pauffley reaches pro futures doubles final in Hambach, Germany A1 Pharmaceuticals LTC Win 3rd Aegon National Open Team Title Aegon Team Tennis National Open Finals: A1 Pharmaceuticals LTC successfully defend their national title. Birkirkara FC v West Ham United the Football Connection A1 Pharmaceuticals founders Gary and Carmen Lewis attend the University of Greenwich, The Chancellor’s Graduation Dinner. A1 Pharmaceuticals One of the Most Cash Rich in the Industry Top 1000 companies that inspire Britain survey includes A1 Pharmaceuticals plc Harry Lewis appointed as the new Director of Purchasing for A1 Pharmaceuticals Plc Carmen Lewis hosts successful Coffee Morning campaign for MacMillan Cancer Support A1 Pharmaceuticals Plc finalist in the Havering Business Awards 2014 A1 become the first Pharmaceutical Wholesaler in the UK to become a ‘Living Wage Employer’ Managing Director Gary Lewis states that we are on target for a record year for sales A1 pledges financial support for local east London junior football team A1 pledges financial support for educating poor children in Africa A1 Tennis Academy wins Aegon Team Tennis National Open Final A1 listed in Sunday Times Profit Track 100 A1 Pharmaceuticals Plc win the highest business award in east London A1 Pharmaceuticals Doubles Duo Hit Hat Trick of Back to Back Futures Titles Marcus Willis sponsored by A1 Pharmaceuticals and managed by Pharmacist Gary Lewis wins Doubles futures title and reaches final of singles at Wrexham. A1 Pharmaceuticals Plc declared as a National Champion in the European Business Awards 2013-2014 Willis Captures Aegon GB Pro-Series Felixstowe Title Devonshire Park confirmed as regional champions A1 Pharmaceuticals triumphs at the Essex Business Awards. Battling Willis shocks 4th seed at Newcastle Futures Marcus Willis, sponsored by A1 Pharmaceuticals, wins Edinburgh Futures Gary Lewis announced as finalist for Essex businessman of the year Willis achieves new PB in ATP World Rankings Inspired Willis makes final of Shrewsbury Futures Brave Willis loses out in Preston semi-final Devonshire Park LTC crowned county champions at Sussex LTA’s Annual General Meeting Marcus Willis upsets the odds to win Glasgow Futures tournament Marcus Willis causes shock upset at Glasgow Futures Historic agreement between A1 Pharmaceuticals PLC and Westcombe Park Sports Club Queens Award Presentation Willis run ends in Quarter Final Orpington secure record win Tennis sponsorship update- November 2012 Queens Award reception – 13th November 2012 Gary Lewis’s profile published in Real Business Jason Barnett storms to World No1 ranking A1 National Finalists in the European Business Awards A1 Pharmaceuticals Plc recognised in Queen’s Birthday honours list A1 Pharmaceuticals Plc launches new look website.
A1 Pharmaceuticals Plc finalist in the Havering Business Awards 2014A1 listed in Sunday Times Profit Track 100A1 Pharmaceuticals Plc wins the highest business award in East LondonA1 Pharmaceuticals Plc declared as a National Champion in the European Business Awards 2013 – 20142013 Essex Countrywide Business Awards – A1 is Growing Business of the YearA1 Pharmaceuticals Plc declared Finalists in the European Business Awards 2012A1 Pharmaceuticals Plc recognised in Queen’s Birthday honours list 2012National Sales Awards 2004 – Sales Professional of the Year AwardNational Business Awards 2009 – Growth Strategy of the Year AwardNational Business Awards 2009 – Entrepreneur of the Year FinalistsErnst & Young Entrepreneur of year Winner 2007National Business Awards 2010- Entrepreneur of the Year FinalistsChamber Award 2011 – Achievement in International BusinessSunday Times International Fast Track 100 (2011) and Fast Track 200 (2012)

Recent Company Performance

Trend in Sales Turnover
The company previously peaked at £35 million annual sales in 2007 and then entered a brief 2 year period of decline literally forcing our then semi retired Chairman & founder Pharmacist Gary Lewis back to leading the company from the helm as Managing Director for the second time in 2008.

Gary quickly devised an austerity plan and changes were created in company policy which has led to strong sustained annual sales growth of 7% since 2000. Record sales of £55 million and pre tax profits circa £4.3 million are expected for the financial year ending April 2016. The managing director is forecasting annual sales of £62 million and record profits in the 30th anniversary year ending April 2017

Investment in people:

The company has heavily reinvested in its people growing its team by a huge 65% in the just 4 years to a record 40 employees this combined with abolishing the UK minimum wage in favour of the significantly higher living wage sends a clear message that this is a progressive caring company that heavily reinvests in its people and their training.

Growing Financial Strength Reflecting in Improved Credit Rating:

Expecting a significant increase on the current Dun & Bradstreet 2A1 credit rating (very low risk of failure) and suggested credit of £1.71 Million (M) after the 2016 accounts are published in July 2016.

Strong Sales, Asset and Profit Growth: 

Sales have grown 62% in 5 years from £32.6M to a record £55M for the year ending April 2016. Pre tax profits in 2015 have increased to a new record of £4.3M from £1.03M in 2011 and net current  assets/working capital have increased by a huge 306%  from £3.15M to a record £12.8M in the same 4 year period this is a testament to the huge reinvestment in the company and illustrates the leaderships confidence and investment in the future.

Awards and Recognition:

Nationally recognised with the achievement of being listed No.28 of over 2 million companies surveyed in the UK  ‘Sunday Times Profit Track 100 in April 2014 and more recently the founders were joint finalists Ernest & Young Entrepreneur 2015. Recently identified in a survey by the London Stock Exchange as one of the “top 1000 most inspirational companies in Britain” of nearly 3 million companies surveyed. In 2016 listed by Grant Thornton for the 3rd successive year in the Essex top 100.

Future Growth:

In spite of sterling(£) weakness in the final quarter of the current  FY 2015/16  bullish sales are suggesting record sales of £62 million in  our 30th anniversary year 2016/17 .

The directors/founders remain confident that their continued policy of reinvestment in its infrastructure and the improving  skills and quality of their team will sustain healthy growth into the medium and long term. The companies highly positive cash flow and strong financial reserves are creating the opportunity and desire for merger and acquisition in 2016 onwards.

Gary and Carmen Lewis, the Founders of A1 Pharmaceuticals Plc would like to take this opportunity to thank their Team, Suppliers and indeed our customers for believing in their leadership and remaining loyal to our cause. Without the dedication and sacrifices of our people these amazing achievements would not have been possible.

 

 

  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
  • A1 Pharmaceuticals Plc
Facebook Iconfacebook like buttonTwitter Icontwitter follow button